Samreen Jamil

Samreen (Sam) Jamil, MD MS, currently serves as the Medical Development Director (Global) for Oncology at Ipsen, a position held since February 2022. Previously, Sam held the role of Associate Director for Oncology in Women's Cancer at Merck and worked as an Oncology Manager at Taiho Oncology, Inc. Additionally, experience includes serving as Study Manager III in Global Oncology at AbbVie, an In-house CRA at Sanofi, and a Clinical Research Coordinator at ID Care. Sam's career in clinical research began as a Clinical Research Associate at Integrated Resources, Inc., following a role as Clinical Research Director at Blue Cross Laboratories Ltd. Educational qualifications include a Master of Science in Clinical Trials: Drug Safety and Pharmacovigilance from Rutgers University, an MD from Baqai Medical University, and an Associate's degree in Pre-Med from St. Lawrence.